A recent study evaluated the efficacy and side effects of donanemab, an antibody that could possibly clear brain amyloid plaque in early symptomatic Alzheimer disease (AD).
FDA Bans Red Dye No. 3 From Foods, Ingested Drugs
The FDA on Wednesday banned the dye called Red 3 from the nation’s food supply and ingested medicines, nearly 35 years after it was barred
January 16, 2025